Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreea Lucia Stancu

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Discoveries (Craiova, Romania)|April 21, 2020
Gut Microbiome and the Response to Immunotherapy in CancerAndreea Lucia Stancu
Frontiers in Endocrinology|October 7, 2022
Thyroid-related adverse events induced by immune checkpoint inhibitorsAlexandra Chera, Andreea Lucia Stancu, Octavian Bucur
Discoveries (Craiova, Romania)|August 18, 2015
New agents for the treatment of lymphoid leukemia and lymphoma: focus on recent FDA approvalsAndreea Lucia Stancu, Mitchell R Smith, Alexandru Almasan
Frontiers in Microbiology|May 14, 2023
Monkeypox: a global health emergencyRuxandra Ilinca Stilpeanu, Ana Maria Stercu, Andreea Lucia Stancu, et al.
Discoveries (Craiova, Romania)|August 18, 2015
PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressorOctavian Bucur, Andreea Lucia Stancu, Maria Sinziana Muraru, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 7, 2013
Poor antibody validation is a challenge in biomedical research: a case study for detection of c-FLIPOctavian Bucur, Bodvael Pennarun, Andreea Lucia Stancu, et al.
Plos One|October 25, 2013
Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cellsOctavian Bucur, Andreea Lucia Stancu, Ioana Goganau, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Discoveries (Craiova, Romania)|April 21, 2020
Gut Microbiome and the Response to Immunotherapy in CancerAndreea Lucia Stancu
Frontiers in Endocrinology|October 7, 2022
Thyroid-related adverse events induced by immune checkpoint inhibitorsAlexandra Chera, Andreea Lucia Stancu, Octavian Bucur
Discoveries (Craiova, Romania)|August 18, 2015
New agents for the treatment of lymphoid leukemia and lymphoma: focus on recent FDA approvalsAndreea Lucia Stancu, Mitchell R Smith, Alexandru Almasan
Frontiers in Microbiology|May 14, 2023
Monkeypox: a global health emergencyRuxandra Ilinca Stilpeanu, Ana Maria Stercu, Andreea Lucia Stancu, et al.
Discoveries (Craiova, Romania)|August 18, 2015
PLK1 is a binding partner and a negative regulator of FOXO3 tumor suppressorOctavian Bucur, Andreea Lucia Stancu, Maria Sinziana Muraru, et al.
Apoptosis : an International Journal on Programmed Cell Death|August 7, 2013
Poor antibody validation is a challenge in biomedical research: a case study for detection of c-FLIPOctavian Bucur, Bodvael Pennarun, Andreea Lucia Stancu, et al.
Plos One|October 25, 2013
Combination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cellsOctavian Bucur, Andreea Lucia Stancu, Ioana Goganau, et al.
Pageof 1